Terada S - Search Results

1

Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses.

Sumida K, Wakita D, Narita Y, Masuko K, Terada S, Watanabe K, Satoh T, Kitamura H, Nishimura T. Sumida K, et al. Among authors: terada s. Eur J Immunol. 2012 Aug;42(8):2060-72. doi: 10.1002/eji.201142335. Eur J Immunol. 2012. PMID: 22653638 Free article.

2

The key role of IL-6-arginase cascade for inducing dendritic cell-dependent CD4(+) T cell dysfunction in tumor-bearing mice.

Narita Y, Kitamura H, Wakita D, Sumida K, Masuko K, Terada S, Nakano K, Nishimura T. Narita Y, et al. Among authors: terada s. J Immunol. 2013 Jan 15;190(2):812-20. doi: 10.4049/jimmunol.1103797. Epub 2012 Dec 17. J Immunol. 2013. PMID: 23248265

3

Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells.

Ohtake J, Kaneumi S, Tanino M, Kishikawa T, Terada S, Sumida K, Masuko K, Ohno Y, Kita T, Iwabuchi S, Shinohara T, Tanino Y, Takemura T, Tanaka S, Kobayashi H, Kitamura H. Ohtake J, et al. Among authors: terada s. J Allergy Clin Immunol. 2015 Dec;136(6):1690-1694. doi: 10.1016/j.jaci.2015.06.050. Epub 2015 Sep 12. J Allergy Clin Immunol. 2015. PMID: 26371842 Free article. No abstract available.

4

Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy.

Ohno Y, Toyoshima Y, Yurino H, Monma N, Xiang H, Sumida K, Kaneumi S, Terada S, Hashimoto S, Ikeo K, Homma S, Kawamura H, Takahashi N, Taketomi A, Kitamura H. Ohno Y, et al. Among authors: terada s. Cancer Sci. 2017 Oct;108(10):1959-1966. doi: 10.1111/cas.13330. Epub 2017 Aug 29. Cancer Sci. 2017. PMID: 28746799 Free PMC article.

5

Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity.

Makishima F, Terada S, Mikami T, Suzuki E. Makishima F, et al. Among authors: terada s. Cytotechnology. 1992;10(1):15-23. doi: 10.1007/BF00376096. Cytotechnology. 1992. PMID: 1369102

6

Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.

Terada S, Suzuki E, Ueda H, Makishima F. Terada S, et al. Cytokine. 1996 Dec;8(12):889-94. doi: 10.1006/cyto.1996.0119. Cytokine. 1996. PMID: 9050746

7

Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle.

Terada S, Fukuoka K, Fujita T, Komatsu T, Takayama S, Reed JC, Suzuki E. Terada S, et al. Cytotechnology. 1997;25(1-3):17-23. doi: 10.1023/a:1007954103572. Cytotechnology. 1997. PMID: 9474804 Free PMC article.

8

Establishing apoptosis resistant cell lines for improving protein productivity of cell culture.

Suzuki E, Terada S, Ueda H, Fujita T, Komatsu T, Takayama S, Reed JC. Suzuki E, et al. Among authors: terada s. Cytotechnology. 1997 Jan;23(1-3):55-9. doi: 10.1023/A:1007942929800. Cytotechnology. 1997. PMID: 22358521 Free PMC article.

9

Characterization and fed-batch culture of hybridoma overexpressing apoptosis suppressing gene bcl-2.

Terada S, Itoh Y, Ueda H, Suzuki E. Terada S, et al. Cytotechnology. 1997 Jul;24(2):135-41. doi: 10.1023/A:1007922104344. Cytotechnology. 1997. PMID: 22358653 Free PMC article.

10

Co-expression of bcl-2 and bag-1, apoptosis suppressing genes, prolonged viable culture period of hybridoma and enhanced antibody production.

Terada S, Komatsu T, Fujita T, Terakawa A, Nagamune T, Takayama S, Reed JC, Suzuki E. Terada S, et al. Cytotechnology. 1999 Sep;31(1-2):143-51. doi: 10.1023/A:1008080407581. Cytotechnology. 1999. PMID: 19003134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

921 results

Search Page

Filters